SCHEMBL5218299

SCHEMBL5218299

Cc1ccc(NC(=O)Nc2nc(CN(C)C(C)C)cs2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.53
▸ MEN1 O00255 4/20 0.53
▸ KMT2A Q03164 4/20 0.53
▸ SMN1; SMN2 Q16637 4/20 0.53
▸ CYP1A2 P05177 3/20 0.53
▸ CYP2C9 P11712 3/20 0.53
▸ CYP2C19 P33261 3/20 0.53
▸ ALDH1A1 P00352 3/20 0.53
▸ LMNA P02545 2/20 0.49
▸ TP53 P04637 1/20 0.49
▸ POLB P06746 3/20 0.48
▸ RAB9A P51151 2/20 0.48
▸ CYP3A4 P08684 2/20 0.47
▸ CYP2D6 P10635 2/20 0.47
▸ NPC1 O15118 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ ITGB1 P05556 1/20 0.43
▸ ITGA4 P13612 1/20 0.43
▸ KDR P35968 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5359387 0.93 MAPT (0.50) MAPTMEN1KMT2ASMN1; SMN2CYP1A2
SCHEMBL5215826 0.88 MAPT (0.47) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL5214312 0.87 MAPT (0.50) MAPTMEN1KMT2ALMNATP53
SCHEMBL5215570 0.85 MAPT (0.43) MAPTMEN1KMT2ASMN1; SMN2LMNA
Cyclopropane SCHEMBL27714655 0.85 AOC3 (0.43) MAPTMEN1KMT2ASMN1; SMN2CYP1A2
SCHEMBL5218842 0.85 MAPT (0.48) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL5217930 0.85 KCNJ6 (0.48) MAPTMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL5218792 0.85 MAPT (0.43) MAPTMEN1KMT2ASMN1; SMN2CYP1A2
SCHEMBL5222457 0.84 RAB9A (0.47) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL5215872 0.84 MAPT (0.42) MAPTMEN1KMT2ASMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1809380-A2 INHIBITORS OF HIV-1 CAPSID FORMATION: SUBSTITUTED ARYL AMINOMETHYL THIAZOLE UREAS AND ANALOGUES THEREOF Achillion Pharmaceuticals, Inc. (US) 2007-07-25 — — EP disclosed
US-7183300-B2 Inhibitors of HIV-1 capsid formation: substituted aryl aminomethyl thiazole ureas and analogues thereof UNIVERSITY OF MARYLAND BALTIMORE COUNTY 2007-02-27 — — US disclosed
WO-2006053323-A2 INHIBITORS OF HIV-1 CAPSID FORMATION: SUBSTITUTED ARYL AMINOMETHYL THIAZOLE UREAS AND ANALOGUES THEREOF ACHILLION PHARMACEUTICALS, INC. (US) 2006-05-18 — — WO disclosed
Send feedback